Limelight Networks (NASDAQ: LLNW), Waters Corporation (NYSE: WAT), Arris Group, Inc. (NASDAQ: ARRS), Boston Scientific (NYSE: BSX), SeaChange (NASDAQ: SEAC) and Check Point Software (NASDAQ: CHKP) get new analyst coverage.
Madison Williams initiated coverage on Waters Corporation (NYSE: WAT) is now covered by analysts at . The analysts placed a “neutral” rating on the company.
Kaufman Brothers initiated coverage on Arris Group, Inc. (ARRS). They placed a “Buy” rating and a price target of $12.00 on the company.
Jefferies (NYSE:JEF) initiated coverage on Limelight Networks (LLNW). They placed a “Buy” rating and a price target of $3.75 on the company.
Mizuho initiated coverage on Boston Scientific (BSX). They placed an “Outperform” rating on the company.
Kaufman Brothers initiated coverage on SeaChange (SEAC). They placed a “Hold” rating and a price target of $9.00 on the company.
Jefferies initiated coverage on Check Point Software (CHKP). They placed a “Buy” rating and a price target of $66.00 on the company.
Showing posts with label ARRIS Group. Show all posts
Showing posts with label ARRIS Group. Show all posts
Friday, August 19, 2011
Wednesday, August 17, 2011
Unilever (UL) (ARRS) (EL) (CRL) (S) (CVD) Upgraded
Unilever (NYSE: UL), Arris Group, Inc. (NASDAQ: ARRS), Estee Lauder Companies Inc (NYSE: EL), Charles River Laboratories (NYSE: CRL), Sprint Nextel (NYSE: S) and Covance Inc. (NYSE: CVD) upgraded by analysts.
Unilever (UL) was upgraded by BNP Paribas from an “Underperform” rating to an “Outperform” rating.
Arris Group, Inc. (ARRS) was upgraded by Avondale Partners from a “Market Perform” rating to an “Outperform” rating. They have a price target of $14.00 on the company, up from $12.00.
Estee Lauder Companies Inc. (EL) was upgraded by BMO Capital Markets from a “Market Perform” rating to an “Outperform” rating. They have a price target of $115.00 on the company, up from $95.00.
Charles River Laboratories (CRL) was upgraded by Lazard Capital from a “Sell” rating to a “Neutral” rating.
Sprint Nextel (S) was upgraded by Collins Stewart from a “Neutral” rating to a “Buy” rating. They have a price target of $5.00 on the company.
Covance Inc. (CVD) was upgraded by Lazard Capital from a “Neutral” rating to a “Buy” rating.
Unilever (UL) was upgraded by BNP Paribas from an “Underperform” rating to an “Outperform” rating.
Arris Group, Inc. (ARRS) was upgraded by Avondale Partners from a “Market Perform” rating to an “Outperform” rating. They have a price target of $14.00 on the company, up from $12.00.
Estee Lauder Companies Inc. (EL) was upgraded by BMO Capital Markets from a “Market Perform” rating to an “Outperform” rating. They have a price target of $115.00 on the company, up from $95.00.
Charles River Laboratories (CRL) was upgraded by Lazard Capital from a “Sell” rating to a “Neutral” rating.
Sprint Nextel (S) was upgraded by Collins Stewart from a “Neutral” rating to a “Buy” rating. They have a price target of $5.00 on the company.
Covance Inc. (CVD) was upgraded by Lazard Capital from a “Neutral” rating to a “Buy” rating.
Wednesday, July 27, 2011
Eaton (ETN) (VECO) (AFFX) (ARRS) (TASR) (RNOW) Ratings Reiterated
Eaton Corp. (NYSE: ETN), Veeco Instruments Inc. (NASDAQ: VECO), Affymetrix, Inc. (NASDAQ: AFFX), Arris Group, Inc. (NASDAQ: ARRS), TASER International, Inc. (NASDAQ: TASR) and RightNow Technologies (NASDAQ: RNOW) ratings reiterated by analysts.
Piper Jaffray reiterated its "Overweight" rating on Veeco Instruments. They have a price target of $62.00 on the company.
Wedbush reiterated a "Neutral" rating on Affymetrix, Inc. (AFFX). They have a price target of $7.00 on the company.
Goldman Sachs (NYSE:GS) reiterated a "Buy" rating on Eaton Corp. (ETN).
Piper Jaffray (NYSE:PJC) reiterated an "Overweight" rating on RightNow Technologies (RNOW). They have a price target of $40.00 on the company.
JPMorgan Chase & Co. (NYSE:JPM) reiterated an "Underweight" rating on TASER International, Inc. (TASR).
Collins Stewart reiterated a “Neutral” rating on Arris Group, Inc. (ARRS).
Piper Jaffray reiterated its "Overweight" rating on Veeco Instruments. They have a price target of $62.00 on the company.
Wedbush reiterated a "Neutral" rating on Affymetrix, Inc. (AFFX). They have a price target of $7.00 on the company.
Goldman Sachs (NYSE:GS) reiterated a "Buy" rating on Eaton Corp. (ETN).
Piper Jaffray (NYSE:PJC) reiterated an "Overweight" rating on RightNow Technologies (RNOW). They have a price target of $40.00 on the company.
JPMorgan Chase & Co. (NYSE:JPM) reiterated an "Underweight" rating on TASER International, Inc. (TASR).
Collins Stewart reiterated a “Neutral” rating on Arris Group, Inc. (ARRS).
Thursday, January 20, 2011
ARRIS Group's (NASDAQ:ARRS) CMTS Revenue Growth to Resume in Third Quarter
With expectations CMTS and Video IP will resume growth in the third quarter for ARRIS Group (NASDAQ:ARRS), UBS raised their estimates on both segments.
UBS says, "We expect ARRS CMTS revs to resume YoY growth in 3Q11 after falling -30% in 2010 and -23% in 1H11 after large capacity purchases by US MSOs in 2009. Easier comps and ongoing strong traffic growth should lead to a return to normalized growth of 10%+ in 2012, and we thus raise our 2012 CMTS growth estimate to 10% from prior est of 2% decline...Our new ests for ARRS FY12 Rev/Non-GAAP EPS are $1.24B/$1.00, up from $1.14B/$0.79 before."
UBS reiterates a "Neutral" rating on ARRIS Group (ARRS), which closed Wednesday at $12.51, down $0.06, or 0.48 percent. UBS raised their price target on ARRIS from $10.40 to $13.
UBS says, "We expect ARRS CMTS revs to resume YoY growth in 3Q11 after falling -30% in 2010 and -23% in 1H11 after large capacity purchases by US MSOs in 2009. Easier comps and ongoing strong traffic growth should lead to a return to normalized growth of 10%+ in 2012, and we thus raise our 2012 CMTS growth estimate to 10% from prior est of 2% decline...Our new ests for ARRS FY12 Rev/Non-GAAP EPS are $1.24B/$1.00, up from $1.14B/$0.79 before."
UBS reiterates a "Neutral" rating on ARRIS Group (ARRS), which closed Wednesday at $12.51, down $0.06, or 0.48 percent. UBS raised their price target on ARRIS from $10.40 to $13.
Subscribe to:
Posts (Atom)